false
Q1
--03-31
2026
0001465470
0001465470
2025-04-01
2025-06-30
0001465470
2026-02-09
0001465470
2025-06-30
0001465470
2025-03-31
0001465470
us-gaap:NonrelatedPartyMember
2025-04-01
2025-06-30
0001465470
us-gaap:RelatedPartyMember
2025-04-01
2025-06-30
0001465470
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2024-03-31
0001465470
us-gaap:CommonStockMember
2024-03-31
0001465470
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001465470
SHMP:StockToBeIssuedMember
2024-03-31
0001465470
SHMP:SubscriptionReceivableMember
2024-03-31
0001465470
us-gaap:RetainedEarningsMember
2024-03-31
0001465470
2024-03-31
0001465470
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2024-04-01
2024-06-30
0001465470
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001465470
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001465470
SHMP:StockToBeIssuedMember
2024-04-01
2024-06-30
0001465470
SHMP:SubscriptionReceivableMember
2024-04-01
2024-06-30
0001465470
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001465470
2024-04-01
2024-06-30
0001465470
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2024-06-30
0001465470
us-gaap:CommonStockMember
2024-06-30
0001465470
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001465470
SHMP:StockToBeIssuedMember
2024-06-30
0001465470
SHMP:SubscriptionReceivableMember
2024-06-30
0001465470
us-gaap:RetainedEarningsMember
2024-06-30
0001465470
2024-06-30
0001465470
SHMP:HydrenesisLLCMember
2025-06-30
0001465470
SHMP:StreetervilleMember
2025-02-11
0001465470
SHMP:BucktownCapitalMember
2025-02-11
0001465470
SHMP:StreetervilleAndBuckstownCapitalMember
2025-02-28
0001465470
us-gaap:RelatedPartyMember
2025-06-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
SHMP:Integer
utr:sqft
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the Quarterly Period Ended June 30, 2025
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the Transition Period from _________ to _________
Commission
file number: 000-54030
NATURALSHRIMP
INCORPORATED
(Exact
name of registrant as specified in its charter)
| Nevada |
|
74-3262176 |
(State
or other Jurisdiction of
Incorporation
or Organization) |
|
(I.R.S.
Employer
Identification
No.) |
P.O.
Box 1256
Dallas,
Texas |
|
75225 |
| (Address
of Principal Executive Offices) |
|
(Zip
Code) |
(972)
951-8035
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
symbol(s) |
|
Name
of exchange on which registered |
| None |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☐ No ☒
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a small reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
| |
|
|
|
| Non-accelerated
filer |
☒ |
Smaller
reporting company |
☒ |
| |
|
|
|
| |
|
Emerging
growth company |
☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act: ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As
of February 9, 2026, there were 1,277,546,746 shares of the registrant’s common stock outstanding.
NATURALSHRIMP
INCORPORATED
FORM
10-Q
FOR
THE THREE MONTHS ENDED JUNE 30, 2025
TABLE
OF CONTENTS
| |
Page |
| |
|
| PART I. FINANCIAL INFORMATION |
3 |
| |
|
|
| ITEM
1. |
Financial Statements |
3 |
| |
|
|
| |
Condensed Consolidated Statements of Net Liabilities in Liquidation as of June 30, 2025 (unaudited) and March 31, 2025 (audited) |
3 |
| |
|
|
| |
Condensed Consolidated Statement of Changes of Net Liabilities in Liquidation for the Three Months Ended June 30, 2025 (unaudited) |
4 |
| |
|
|
| |
Condensed Consolidated Statement of Operations for the three months ended June 30, 2024 (unaudited) |
5 |
| |
|
|
| |
Condensed Consolidated Statement of Changes in Shareholders’ Equity for the three months ended June 30, 2024 (unaudited) |
6 |
| |
|
|
| |
Condensed Consolidated Statement of Cash Flows for the Three Months Ended June 30, 2024 (unaudited) |
7 |
| |
|
|
| |
Notes to Condensed Consolidated Financial Statements (unaudited) |
8 |
| |
|
|
| ITEM
2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
11 |
| |
|
|
| ITEM
3. |
Quantitative and Qualitative Disclosures about Market Risk |
12 |
| |
|
|
| ITEM
4. |
Controls and Procedures |
12 |
| |
|
|
| PART II. OTHER INFORMATION |
13 |
| |
|
|
| ITEM
1. |
Legal Proceedings |
13 |
| |
|
|
| ITEM
1A. |
Risk Factors |
14 |
| |
|
|
| ITEM
2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
14 |
| |
|
|
| ITEM
3. |
Defaults Upon Senior Securities |
14 |
| |
|
|
| ITEM
4. |
Mine Safety Disclosures |
14 |
| |
|
|
| ITEM
5. |
Other Information |
14 |
| |
|
|
| ITEM
6. |
Exhibits |
14 |
| |
|
|
| SIGNATURES |
15 |
PART
I – FINANCIAL INFORMATION
Item
1. Financial Statements
NATURALSHRIMP
INCORPORATED AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENT OF NET LIABILITIES IN LIQUIDATION
(Liquidation
Basis)
| | |
June 30, 2025 | | |
March 31, 2025 | |
| | |
As of | |
| | |
June 30, 2025 | | |
March 31, 2025 | |
| | |
(Unaudited) | | |
| |
| | |
| | |
| |
| Cash | |
| 184,967 | | |
| 101,969 | |
| Current assets | |
| - | | |
| 193,865 | |
| Fixed assets and intangibles | |
| - | | |
| 35,800,000 | |
| Other assets | |
| - | | |
| 86,330 | |
| Accounts payable and accrued expenses | |
| (6,719,824 | ) | |
| (6,809,772 | ) |
| Notes payable and lines of credit | |
| (1,179,832 | ) | |
| (37,200,851 | ) |
| Other liabilities | |
| (933,993 | ) | |
| (962,553 | ) |
| Net liabilities in liquidation | |
| (8,648,682 | ) | |
| (8,791,012 | ) |
The
accompanying notes are an integral part of these consolidated financial statements.
NATURALSHRIMP
INCORPORATED AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENT OF CHANGES IN NET LIABILITIES IN LIQUIDATION
(Liquidation
Basis)
(Unaudited)
| | |
For the Three Months Ended June 30, 2025 | |
| Net liabilities in liquidation, March 31, 2025 | |
$ | (8,791,012 | ) |
| | |
| | |
| Changes in assets and liabilities in liquidation: | |
| | |
| Cash | |
| 82,998 | |
| Write-off of assets | |
| (280,195 | ) |
| Transfer of fixed assets and intangibles to creditor | |
| (35,800,000 | ) |
| Settlement of accounts payable and accrued expenses | |
| 89,948 | |
| Extinguishment of notes payable and lines of credit | |
| 36,021,019 | |
| Extinguishment of other liabilities | |
| 28,560 | |
| Net changes in liabilities in liquidation | |
| 142,330 | |
| | |
| | |
| Net liabilities in liquidation, June 30, 2025 | |
$ | (8,648,682 | ) |
The
accompanying notes are an integral part of these Condensed Consolidated financial statements.
NATURALSHRIMP
INCORPORATED
CONDENSED
Consolidated STATEMENTS OF OPERATIONS
(Going
Concern Basis)
(Unaudited)
| | |
Three Months Ended June 30, 2024 | |
| | |
| |
| Sales | |
$ | 36,618 | |
| Cost of sales | |
| 34,732 | |
| Net revenue | |
| 1,886 | |
| | |
| | |
| Operating expenses: | |
| | |
| General and administrative | |
| 1,104,485 | |
| Facility operations | |
| 158,535 | |
| Depreciation | |
| 434,908 | |
| Amortization | |
| 367,500 | |
| Total operating expenses | |
| 2,065,428 | |
| | |
| | |
| Net loss from operations | |
| (2,063,542 | ) |
| | |
| | |
| Other income (expense): | |
| | |
| Interest expense | |
| (3,899 | ) |
| Interest expense - related parties | |
| (9,750 | ) |
| Interest expense | |
| (9,750 | ) |
| Change in fair value of warrant liability | |
| 5,000 | |
| Change in fair value of restructured notes payable | |
| (720,000 | ) |
| Extension fee | |
| - | |
| (Loss) gain on sale of machinery and equipment | |
| (10,357 | ) |
| | |
| | |
| Total other income (expense), net | |
| (739,006 | ) |
| | |
| | |
| | |
| | |
| Provision for income taxes | |
| - | |
| | |
| | |
| Net loss | |
| (2,802,548 | ) |
| | |
| | |
| Accretion on Preferred shares | |
| (48,300 | ) |
| Dividends | |
| (75,097 | ) |
| | |
| | |
| Net loss available for common stockholders | |
$ | (2,925,945 | ) |
| | |
| | |
| Loss per share (Basic and Diluted) | |
$ | (0.00 | ) |
| | |
| | |
| WEIGHTED AVERAGE SHARES OUTSTANDING (Basic and Diluted) | |
| 1,167,281,937 | |
The
accompanying footnotes are an integral part of these condensed consolidated financial statements
NATURALSHRIMP
INCORPORATED
CONDENSED
Consolidated STATEMENT of CHANGES IN SHAREHOLDERS’ DEFICIT
For
the three months ended June 30, 2024
(Going
Concern Basis)
(Unaudited)
| | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
in Capital | | |
issued | | |
receivable | | |
deficit | | |
deficit | |
| | |
Series A
Preferred stock | | |
Common stock | | |
Additional paid | | |
Stock to be | | |
Subscription | | |
Accumulated | | |
Total stockholders’ | |
| | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
in Capital | | |
issued | | |
receivable | | |
deficit | | |
deficit | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Balance March 31, 2024 | |
| 5,000,000 | | |
$ | 500 | | |
| 1,116,482,063 | | |
$ | 111,712 | | |
$ | 126,468,749 | | |
$ | 390,024 | | |
$ | (56,250 | ) | |
$ | (183,791,156 | ) | |
| (56,876,421 | ) |
| Balance | |
| 5,000,000 | | |
$ | 500 | | |
| 1,116,482,063 | | |
$ | 111,712 | | |
$ | 126,468,749 | | |
$ | 390,024 | | |
$ | (56,250 | ) | |
$ | (183,791,156 | ) | |
| (56,876,421 | ) |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Issuance of common shares under financing agreement | |
| - | | |
| - | | |
| 66,392,019 | | |
| 6,639 | | |
| 479,200 | | |
| - | | |
| - | | |
| - | | |
| 485,839 | |
| Shares issued upon exchange of Partitioned Note | |
| - | | |
| - | | |
| 10,000,000 | | |
| 1,000 | | |
| 99,000 | | |
| - | | |
| - | | |
| - | | |
| 100,000 | |
| Accretion of Series E Preferred stock | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (9,300 | ) | |
| (9,300 | ) |
| Accretion on Series G Preferred stock | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (39,000 | ) | |
| (39,000 | ) |
| Dividends payable on Preferred stock | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (75,097 | ) | |
| (75,097 | ) |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (2,802,548 | ) | |
| (2,802,548 | ) |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Balance June 30, 2024 | |
| 5,000,000 | | |
$ | 500 | | |
| 1,192,874,082 | | |
$ | 119,351 | | |
$ | 127,046,949 | | |
$ | 390,024 | | |
$ | (56,250 | ) | |
$ | (186,717,101 | ) | |
| (59,216,527 | ) |
| Balance | |
| 5,000,000 | | |
$ | 500 | | |
| 1,192,874,082 | | |
$ | 119,351 | | |
$ | 127,046,949 | | |
$ | 390,024 | | |
$ | (56,250 | ) | |
$ | (186,717,101 | ) | |
| (59,216,527 | ) |
The
accompanying footnotes are an integral part of these condensed consolidated financial statements.
NATURALSHRIMP
INCORPORATED
CONDENSED
Consolidated STATEMENTS OF CASH FLOWS
(Going
Concern Basis)
(Unaudited)
| | |
For Three Months Ended June 30, 2024 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | |
| | |
| Net loss | |
$ | (2,802,548 | ) |
| | |
| | |
| Adjustments to reconcile net loss to net cash used in operating activities | |
| | |
| | |
| | |
| Depreciation expense | |
| 434,908 | |
| Amortization expense | |
| 367,500 | |
| Change in fair value of warrant liability | |
| (5,000 | ) |
| Change in fair value of restructured notes payable | |
| 720,000 | |
| Financing costs | |
| 7,300 | |
| (Loss) gain on sale of machinery and equipment | |
| 10,357 | |
| Shares issued for services | |
| - | |
| Amortization of operating lease right-of-use assets | |
| 3,732 | |
| | |
| | |
| Changes in operating assets and liabilities: | |
| | |
| Accounts receivable | |
| 5,285 | |
| Inventory | |
| 8,158 | |
| Prepaid expenses | |
| 8,177 | |
| Deferred offering costs | |
| - | |
| Accounts payable | |
| 189,038 | |
| Other accrued expenses | |
| 99,079 | |
| Accrued expenses - related parties | |
| 142,652 | |
| Accrued interest - related parties | |
| 9,750 | |
| Operating lease liabilities | |
| (4,773 | ) |
| | |
| | |
| Cash used in operating activities | |
| (806,385 | ) |
| | |
| | |
| CASH FLOWS FROM INVESTING ACTIVITIES | |
| | |
| | |
| | |
| Cash paid for fixed assets | |
| - | |
| Cash received for sale of machinery and equipment | |
| 10,000 | |
| | |
| | |
| Cash provided by (used in) investing activities | |
| 10,000 | |
| | |
| | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |
| | |
| | |
| | |
| Payments of notes payable | |
| - | |
| Proceeds from sale of stock | |
| 485,838 | |
| Proceeds from sale of Series G Preferred Shares | |
| 200,000 | |
| | |
| | |
| Cash provided by financing activities | |
| 685,838 | |
| | |
| | |
| NET CHANGE IN CASH | |
| (110,547 | ) |
| | |
| | |
| CASH AT BEGINNING OF PERIOD | |
| 115,525 | |
| | |
| | |
| CASH AT END OF PERIOD | |
$ | 4,978 | |
| | |
| | |
| INTEREST PAID | |
$ | 3,899 | |
| | |
| | |
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | |
| | |
| Shares issued upon conversion of Preferred stock | |
$ | - | |
| Shares issued upon exchange of Partitioned Note | |
$ | 100,000 | |
| Dividends on Series E Preferred stock | |
$ | - | |
| Dividends in kind issued | |
$ | 75,097 | |
| Shares issued/to be issued, for legal settlement | |
$ | - | |
The
accompanying footnotes are an integral part of these condensed consolidated financial statements.
NATURALSHRIMP
INCORPORATED
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE MONTHS ENDED JUNE 30, 2025
(Unaudited)
NOTE
1 – NATURE OF THE ORGANIZATION AND BUSINESS
NaturalShrimp
Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a former biotechnology company that
was focused on growing Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density,
low-cost environment, and in fully contained and independent production facilities.
The
Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation (“NSC”) and NaturalShrimp Global, Inc.
(“NS Global”) and Natural Aquatic Systems, Inc. (“NAS”), and owns 51% of NaturalShrimp/Hydrenesis LLC, a Texas
limited liability company.
Receivership
and Liquidation
On
September 4, 2024, Streeterville Capital, LLC, a Utah limited liability company, and Bucktown Capital, LLC, a Utah limited liability
company (collectively, “Lenders”), filed a Verified Emergency Motion for Appointment of Receiver (the “Motion”)
under Civil Case No. 240907138, in the District Court of Salt Lake County, Utah, against NaturalShrimp, Inc. (“NaturalShrimp”).
The
Motion alleged, among other things, that NaturalShrimp had defaulted under the terms of its loan agreements with the Lenders. The Motion
sought the appointment of a Receiver to immediately take control of NaturalShrimp’s assets.
An
order was entered ex parte by the Utah State Court in the Receivership Case on September 9, 2024 granting the relief requested by Lenders.
The Utah State Court duly appointed Amplēo Turnaround and Restructuring, LLC (the “Receiver”) as the receiver over
NaturalShrimp’s assets. The Utah State Court’s order further scheduled a hearing to be held on September 17, 2024, on a preliminary
injunction to address issues raised in the Motion.
On
November 20, 2024, the Lenders and NaturalShrimp filed a Verified Amended and Stipulated Emergency Motion for Immediate Appointment
of a Receiver in the Receivership Case.
On
November 22, 2024, the Utah State Court entered an order granting the Stipulated Motion and appointed Receiver as the receiver over the
assets of NaturalShrimp.
On February
11, 2025, the Receiver filed a Motion for Approval to Sell Substantially all of the Receivership Entities’ Assets to Streeterville
Captial, LLC and Bucktown Captial, LLC (or Their Designees) or Any Other Party With a Higher and Better Offer Free and Clear of All Liens,
Interests, Claims, and Encumbrances (the “Sale Motion”) in the Receivership Case. The Sale Motion sought the Utah State
Court’s approval for the Receiver to sell substantially all of the Receivership Entities’ assets free and clear of all liens,
interests, claims, and encumbrances to Streeterville and Bucktown Capital, through their designated entities, NaturalShrimp Farms, Inc.
(“NV Purchaser”), a Nevada corporation, Iowa Shrimp Holdings, LLC (“IA Purchaser”), an Iowa limited liability
company, Texas Shrimp Holdings, LLC (“TX Purchaser” or together with NV Purchaser and IA Purchaser, the “Purchasers”),
a Texas limited liability company, for a roughly $35,703,789.87 credit bid (based on a secured and administrative claim basis) and $100,000
cash, pursuant to the terms and conditions set forth in that certain Asset Purchase Agreement (“APA”) between Trustee and
Purchasers. The order to sell the assets was approved on March 30, 2025 and the title to the assets was transferred to the lenders on
May 14, 2025.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
Condensed Consolidated financial statements have been prepared in accordance with United States generally accepted accounting
principles (“US GAAP”). As the Company’s liquidation became imminent as of March 30, 2025, the Company has
presented its financial statements under the liquidation basis of accounting as of both June 30, 2025 and March 31, 2025. To comply
with ASC 205-30, Liquidation Basis of Accounting, the Company has presented a condensed consolidated statement of net
liabilities in liquidation as of June 30, 2025 and March 31, 2025 and a condensed consolidated statement of changes of net
liabilities in liquidation for the three months ended June 30, 2025. In addition, to comply with the financial statement
requirements of Article 8 of Regulation S-X, the Company has also presented a condensed consolidated statement of operations, a
condensed consolidated statement of changes in shareholders equity and a condensed consolidated statement of cash flows for the
three months ended June 30, 2024 under the going concern basis of accounting. The going concern financial statements have been
presented separately from the liquidation basis financial statements as the results should not be considered comparable under the
two presentation methods. The interim financial statements should be read in conjunction with the audited consolidated financial
statements, including the notes thereto, included in our 2025 Annual Report on Form 10-K that was filed with the Securities and Exchange Commission on November 5, 2025.
Consolidation
The
condensed consolidated financial statements include the accounts of NaturalShrimp Incorporated and its wholly-owned subsidiaries, NaturalShrimp
USA Corporation, NaturalShrimp Global and NAS, and the 51% ownership of NaturalShrimp/Hydrenesis LLC. All significant intercompany accounts
and transactions have been eliminated in consolidation.
Use
of Estimates
Preparing
financial statements in conformity with accounting principles generally accepted in the United States of America requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates.
Liquidation
Basis of Accounting
In
accordance with ASC 205-30, Liquidation Basis of Accounting, the Company prepares its financial statements using the liquidation
basis of accounting when liquidation is imminent. Liquidation is considered imminent when either of the following occurs-i) A plan for
liquidation has been approved by the person or persons with the authority to make such a plan effective, and the likelihood is remote
that either execution of the plan will be blocked by other parties or the entity will return from liquidation and ii) A plan for liquidation
is imposed by other forces, and the likelihood is remote that the entity will return from liquidation.
When
using the liquidation basis of accounting, the Company will i) recognize other items that it previously had not recognized but it expects
to sell in liquidation or use to settle liabilities ii) accrue costs and income that it expects to incur or earn through the end of its
liquidation if and when it has a reasonable basis for estimation iii) measure its assets to reflect the estimated amount of cash or other
consideration that it expects to collect in settling or disposing of those assets in carrying out its plan for liquidation and iv) measure
its liabilities in accordance with the measurement provision of other topics that it would otherwise apply to those liabilities.
Financial
Instruments
The
Company’s financial instruments include cash and cash equivalents, payables and debt and are accounted for under the provisions
of ASC Topic 825, “Financial Instruments”. The carrying amount of these financial instruments in the condensed consolidated
balance sheets approximates fair value.
Cash
and Cash Equivalents
The
Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. There were
no cash equivalents as of June 30, 2025 and March 31, 2025.
Recently
Issued Accounting Standards
As
the Company is currently reporting under the liquidation basis of accounting, it does not believe that there are any recently issued
accounting standards that would be material to its financial statements.
NOTE
3 – LIQUIDATION BASIS OF ACCOUNTING
During
September of 2024, Ampleo Turnaround and Restructuring, LLC was placed as the receiver over the Company’s assets due to its significant
outstanding debt. Subsequently, during February of 2025, the receiver filed a motion to sell all of the Company’s assets to Streeterville
and Bucktown Capital for an approximate credit bid of $35.7 million and $0.1 million in cash. The motion was approved by the court (overseeing
the motion) on March 30, 2025 with title to the assets being transferred to the creditor on May 14, 2025. The Company believes that it
continued to function as a going concern until the date the motion to sell its assets was approved by the court at which time its liquidation
became imminent. As such, in accordance with the ASC 205-30, the Company has presented i) a condensed consolidated statement of net liabilities
in liquidation as of both June 30, 2025 and March 31, 2025 and ii) a condensed consolidated statement of changes in net liabilities in
liquidation for the period ended June 30, 2025. The condensed consolidated statements of net liabilities in liquidation and statement
of changes of net liabilities in liquidation have been prepared using the liquidation basis of accounting.
As
part of the liquidation, the Company transferred ownership of its revenue generating fixed assets and intangible assets on May 14, 2025
to two of its creditors (Streeterville and Buckstown) in exchange for the extinguishment of i) the restructured August and Senior notes
and Buckstown line of credit. As of the date of this filing, the Company had limited assets available and was therefore uncertain as
to the manner by which it expects to settle its remaining outstanding liabilities. Furthermore, we are also uncertain about the date
by which we expect to complete the liquidation.
Our
condensed consolidated statement of net liabilities in liquidation as of June 30, 2025 and March 31, 2025 reflects the following:
| |
● |
No
additional items were recognized, such as trademarks, that the Company might either sell in liquidation or use to settle its liabilities |
| |
● |
Liabilities
have been recognized in accordance with the recognition provisions of other topics that otherwise would apply to those liabilities.
As of June 30, 2025, our remaining liabilities were primarily comprised of accounts payable and accrued expenses to finance and legal
service providers, accrued salaries and remaining outstanding debt. Of the $8.7 million in outstanding liabilities as of June 30, 2025 approximately
$3.0 million was to related parties. |
| |
● |
The
intangible assets and fixed assets were recognized based on a settlement amount equal to the credit bid of approximately $35,800,000
as of March 31, 2025. As of June 30, 2025, intangible assets and fixed assets were fully de-recognized due to ownership of the assets
being transferred to our creditors as of May 14, 2025. |
| |
● |
No
additional costs or income expected to be incurred or earned through the end of our liquidation were accrued as of March 31, 2025 as
the Company did not have a reasonable basis for estimation. However, as of June 30, 2025 costs and income expected to be incurred or
earned were accrued through December 31, 2025. The amounts accrued subsequent to the balance sheet date were primarily comprised of
legal and accounting fees and were not material. |
NOTE
4 – SUBSEQUENT EVENTS
In
accordance with ASC 855, Subsequent Events, the Company evaluated all events or transactions that occurred after the balance sheet
date but before the financial statements were issued. To that extent, the Company noted no material events or transactions to be disclosed.
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
As
used in this Quarterly Report on Form 10-Q and unless otherwise indicated, the terms “Company,” “we,” “us,”
and “our” refer to NaturalShrimp Incorporated and its wholly-owned subsidiaries NSC, NS Global and NAS. The Company also
owns 51% of NaturalShrimp/Hydrenesis LLC, a Texas limited liability company. Unless otherwise specified, all dollar amounts are expressed
in United States Dollars.
Use
of Generally Accepted Accounting Principles (“GAAP”) Financial Measures
We
use United States GAAP financial measures, unless otherwise noted. All of the GAAP financial measures used by us in this report relate
to the inclusion of financial information. This discussion and analysis should be read in conjunction with our financial statements and
the notes thereto included elsewhere in this quarterly report. All references to dollar amounts in this section are in United States
dollars, unless expressly stated otherwise.
Overview
NaturalShrimp
Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a former biotechnology company that
was focused on growing Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density,
low-cost environment, and in fully contained and independent production facilities.
The
Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation (“NSC”) and NaturalShrimp Global, Inc.
(“NS Global”) and Natural Aquatic Systems, Inc. (“NAS”), and owns 51% of NaturalShrimp/Hydrenesis LLC, a Texas
limited liability company.
Receivership
and Liquidation
On
September 4, 2024, Streeterville Capital, LLC, a Utah limited liability company, and Bucktown Capital, LLC, a Utah limited liability
company (collectively, “Lenders”), filed a Verified Emergency Motion for Appointment of Receiver (the “Motion”)
under Civil Case No. 240907138, in the District Court of Salt Lake County, Utah, against NaturalShrimp, Inc. (“NaturalShrimp”).
The
Motion alleged, among other things, that NaturalShrimp had defaulted under the terms of its loan agreements with the Lenders. The Motion
sought the appointment of a Receiver to immediately take control of NaturalShrimp’s assets to preserve the same.
An
order was entered ex parte by the Utah State Court in the Receivership Case on September 9, 2024 granting the relief requested by Lenders.
The Utah State Court duly appointed Amplēo Turnaround and Restructuring, LLC (the “Receiver”) as the receiver over
NaturalShrimp’s assets. The Utah State Court’s order further scheduled a hearing to be held on September 17, 2024, on a preliminary
injunction to address issues raised in the Motion.
On
November 20, 2024, the Lenders and NaturalShrimp filed a Verified Amended and Stipulated Emergency Motion for Immediate Appointment
of a Receiver in the Receivership Case.
On
November 22, 2024, the Utah State Court entered an order granting the Stipulated Motion and appointed Receiver as the receiver over the
assets of NaturalShrimp.
On
February 11, 2025, the Receiver filed a Motion for Approval to Sell Substantially all of the Receivership Entities’ Assets to
Streeterville Captial, LLC and Bucktown Captial, LLC (or Their Designees) or Any Other Party With a Higher and Better Offer Free and
Clear of All Liens, Interests, Claims, and Encumbrances (the “Sale Motion”) in the Receivership Case. The Sale Motion
sought the Utah State Court’s approval for the Receiver to sell substantially all of the Receivership Entities’ assets free
and clear of all liens, interests, claims, and encumbrances to Streeterville and Bucktown Capital, through their designated entities,
NaturalShrimp Farms, Inc. (“NV Purchaser”), a Nevada corporation, Iowa Shrimp Holdings, LLC (“IA Purchaser”),
an Iowa limited liability company, Texas Shrimp Holdings, LLC (“TX Purchaser” or together with NV Purchaser and IA Purchaser,
the “Purchasers”), a Texas limited liability company, for a roughly $35,703,789.87 credit bid (based on a secured and administrative
claim basis) and $100,000 cash, pursuant to the terms and conditions set forth in that certain Asset Purchase Agreement (“APA”)
between Trustee and Purchasers. The order to sell the assets was approved on March 30, 2025 and the title to the assets was transferred
to the lenders on May 14, 2025.
Liquidity
and Capital Resources
The
Company had limited liquidity as of June 30, 2025 and is currently working on a plan with its existing creditors on how to settle
its remaining outstanding obligations, which were primarily comprised of i) payables to finance and legal service providers ii)
accrued salaries and iii) loans and the corresponding accrued interest.
Results
of Operations
During
the three months ended June 30, 2025, the Company settled its outstanding liabilities to both Streeterville and Buckstown (approximately
$36 million as of March 31, 2025) through the transfer of ownership rights to its fixed assets and intangible assets. As of
the date of the transfer, i) the outstanding debt to those entities was considered extinguished and ii) the fixed assets and intangible
assets were derecognized. The Company had limited other activity during the period.
Critical
Accounting Estimates
Liquidation
Basis of Accounting
In
accordance with ASC 205-30, Liquidation Basis of Accounting, the Company prepares its financial statements using the liquidation
basis of accounting when liquidation is imminent. Liquidation is considered imminent when either of the following occurs-i) A plan for
liquidation has been approved by the person or persons with the authority to make such a plan effective, and the likelihood is remote
that either execution of the plan will be blocked by other parties or the entity will return from liquidation and ii) A plan for liquidation
is imposed by other forces, and the likelihood is remote that the entity will return from liquidation.
When
using the liquidation basis of accounting, the Company will i) recognize other items that is previously had not recognized but it expects
to sell in liquidation or use to settle liabilities ii) accrue costs and income that it expects to incur or earn through the end of its
liquidation if and when it has a reasonable basis for estimation iii) measure its assets to reflect the estimated amount of cash or other
consideration that it expects to collect in settling or disposing of those assets in carrying out its plan for liquidation and iv) measure
its liabilities in accordance with the measurement provision of other topics that it would otherwise apply to those liabilities.
Recently
Issued Accounting Standards
As
the Company is currently reporting under the liquidation basis of accounting, it does not believe that there are any recently issued
accounting standards that would be material to its financial statements.
Item
3. Quantitative and Qualitative Disclosures about Market Risk
Not
Applicable. As a smaller reporting company, we are not required to provide the information required by this Item.
Item
4. Controls and Procedures
Evaluation
of Disclosure Controls and Procedures
We
maintain a system of disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to provide reasonable assurance that information
required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including
our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.
In
designing and evaluating our disclosure controls and procedures, management recognizes that any disclosure controls and procedures, no
matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition,
the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required
to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
The
Company’s management, with the participation of our principal executive officer and principal financial officer, has evaluated
the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of
the Exchange Act, as of the end of the period covered by this Report.
Based
upon that evaluation , our principal executive officer and principal financial officer concluded that, as of June 30, 2025, our disclosure
controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below.
Thus, there remains a reasonable possibility that a material misstatement of the Company’s interim financial statements will not
be prevented or detected on a timely basis. This does not include an evaluation by the Company’s registered public accounting firm
regarding the Company’s internal control over financial reporting. Accordingly, we cannot provide reasonable assurance that information
required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, to
allow our principal financial and executive officers to make timely decisions regarding required disclosures as of June 30, 2025.
Management’s
evaluation was based on the following material weaknesses in our internal control over financial reporting which existed as of March
31, 2025, and which continue to exist, as discussed in the Company’s Annual Report on Form 10-K:
| ● |
Inadequate
segregation of duties consistent with control objectives; |
| ● |
Lack
of independent board of directors (as of the balance sheet date) and absence of an audit committee to exercise oversight responsibility
related to financial reporting and internal control; |
| ● |
Lack
of risk assessment procedures on internal controls to detect financial reporting risks in a timely manner; and |
| ● |
Lack
of documentation on policies and procedures that are critical to the accomplishment of financial reporting objectives. |
Our
management will continue to monitor and evaluate the relevance of our risk-based approach and the effectiveness of our internal controls
and procedures over financial reporting on an ongoing basis and is committed to taking further action and implementing additional enhancements
or improvements, as necessary and as funds allow.
Changes
in Internal Control over Financial Reporting
There
have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange
Act) during the fiscal quarter ended June 30, 2025 that have materially affected, or that are reasonably likely to materially affect,
our internal control over financial reporting.
PART
II – OTHER INFORMATION
Item
1. Legal Proceedings
While
the company is currently in the process of trying to settle its remaining outstanding debts it was not involved in any legal proceedings
as of the date of the filing. Further, the outstanding legal proceeding with Streeterville and Buckstown was considered settled upon
the transfer of its assets to those entities in settlement of its outstanding debt.
Item
1A. Risk Factors
As
a smaller reporting Company (“SRC”) we are not required to provide this information.
Item
2. Unregistered Sales of Equity Securities and Use Of Proceeds
Not
applicable
Item
3. Defaults upon Senior Securities
Not
applicable
Item
4. Mine Safety Disclosures
Not
Applicable.
Item
5. Other Information
None.
Item
6. Exhibits
EXHIBIT
INDEX
| |
|
|
|
Incorporated
by Reference |
| Exhibit
Number |
|
Exhibit
Description |
|
Form |
|
Exhibit |
| 31.1* |
|
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer. |
|
|
|
|
| 31.2* |
|
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer. |
|
|
|
|
| 32.1** |
|
Section 1350 Certification of Chief Executive Officer. |
|
|
|
|
| 32.2** |
|
Section 1350 Certification of Chief Financial Officer. |
|
|
|
|
| 101.INS* |
|
Inline
XBRL Instance Document |
|
|
|
|
| 101.SCH* |
|
Inline
XBRL Taxonomy Extension Schema Document |
|
|
|
|
| 101.CAL* |
|
Inline
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
|
| 101.DEF* |
|
Inline
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
|
|
| 101.LAB* |
|
Inline
XBRL Taxonomy Extension Label Linkbase Document |
|
|
|
|
| 101.PRE* |
|
Inline
XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
|
|
*
Filed herewith.
**
Furnished herewith.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
NATURALSHRIMP
INCORPORATED
| By: |
/s/
Gerald Easterling |
|
| |
Gerald
Easterling |
|
| |
Chief
Executive Officer |
|
| |
(Principal
Executive Officer) |
|
| Date: |
February 17, 2026 |
|
| By: |
/s/
William Delgado |
|
| |
William
Delgado |
|
| |
Chief
Financial Officer |
|
| |
(Principal
Financial Officer and Principal Accounting Officer) |
|
| Date: |
February 17, 2026 |
|